Ronald R. Fieve

Ronald R. Fieve's AcademicInfluence.com Rankings

Ronald R. Fieve

Biology

#10053

World Rank

#13338

Historical Rank

biology Degrees

Download Badge

Biology

Ronald R. Fieve's Degrees

Masters Medicine Columbia University

Why Is Ronald R. Fieve Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ronald R. Fieve's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical factors in lithium carbonate prophylaxis failure. (1974) (498)
Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study. (1974) (335)
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. (2003) (190)
A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients (1991) (180)
Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder: Double-blind, Placebo-Controlled Comparison of BID versus TID Dosing (2005) (166)
Relationship between the effectiveness of lithium therapy and family history. (1973) (156)
The use of lithium in affective disorders. I. Acute endogenous depression. (1968) (152)
The course of development of mania in patients with recurrent depression. (1976) (148)
Quality of life in patients with bipolar I depression: data from 920 patients. (2004) (145)
Rapid cycling manic depressive patients. (1977) (143)
The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. (1973) (143)
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. (1976) (135)
Evidence for X-linkage in the transmission of manic-depressive illness. (1972) (134)
Clinical and psychological assessment of children of bipolar probands. (1983) (129)
Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. (1976) (128)
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. (1978) (107)
Manic-Depressive Illness: A Comparative Study of Patients with and Without a Family History (1972) (106)
Life events at the onset of bipolar affective illness. (1979) (101)
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. (1992) (96)
Lithium carbonate and plasma cortisol response in the ffective disorders. (1968) (95)
Relationship between hypomania and personality disorders before and after successful treatment. (1995) (91)
The life table. A method for analyzing longitudinal studies. (1976) (91)
Bipolar illness: a prospective study of life events. (1977) (86)
Toward the validation of RDC schizoaffective disorder. (1980) (82)
A study comparing paroxetine placebo and imipramine in depressed patients. (1993) (80)
The effect of lithium treatment on thyroid function in patients with primary affective disorder. (1979) (79)
Lithium Carbonate Prophylaxis Failure (1976) (79)
Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects. (1990) (79)
Melancholic/endogenous depression and response to somatic treatment and placebo. (1992) (77)
The use of lithium in the affective psychoses. (1966) (74)
The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder. (1968) (73)
Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy. (1992) (73)
Menstrual problems in women with primary affective illness. (1976) (71)
Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. (1983) (71)
Bipolar illness: factors in drinking behavior. (1979) (70)
Rubidium: a Potential Modifier of Affect and Behaviour (1969) (68)
Cardiac sinus node dysfunction during lithium treatment. (1979) (64)
Lithium treatment in older patients. (1979) (63)
Personality Traits During Depression and After Clinical Recovery (1994) (63)
The role of electrolytes in affective disorders. Sodium, potassium, and lithium ions. (1970) (62)
Disorders of decision in affective disease: An effect of β-adrenergic dysfunction? (1990) (61)
Rubidium: biochemical, behavioral, and metabolic studies in humans. (1973) (60)
Disappearance of memory deficits in outpatient depressives responding to imipramine. (1991) (60)
Lithium Prophylaxis of Bipolar Illness (1994) (57)
Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics. (1986) (57)
Depressive symptoms in patients with unipolar and bipolar affective disorder. (1976) (53)
Emotion profiles associated with mania and depression. (1969) (52)
Statistical predictions of suicide in depressives. (1980) (52)
Unipolar mania: a distinct clinical entity? (1979) (51)
Mechanisms of renal lithium handling and their relationship to mineralocorticoids: a dissociation between sodium and lithium ions. (1971) (51)
Social Outcome Compared in Psychotic and Nonpsychotic Bipolar I Patients (1983) (49)
Lithium carbonate and weight gain. (1980) (49)
Lithium and thyroid function in manic-depressive psychosis. (1968) (48)
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. (1982) (48)
The dexamethasone suppression test in depressed outpatients and normal control subjects. (1983) (48)
Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. (1975) (47)
Incidence of side effects in patients on long-term lithium therapy. (1980) (47)
Longitudinal Studies of Diurnal Variations in Depression: A Sample of 643 Patient Days (1973) (46)
Manic-depressive illness: linkage with the Xg blood group. (1973) (46)
Genetic history as a predictor of lithium response in manic-depressive illness. (1972) (45)
On the use of inverted factor analysis for generating typologies. (1971) (44)
Assortative mating in primary affective disorder. (1976) (43)
Prediction of lithium dose: a mathematical alternative to the test-dose method. (1986) (42)
The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo. (1989) (40)
Search for biological/genetic markers in a long-term epidemiological and morbid risk study of affective disorders. (1984) (40)
Personality traits and response to desipramine. (1992) (40)
Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. (1979) (38)
Psychopathology among children of manic-depressive patients. (1980) (38)
Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. (2007) (38)
Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate. (1987) (37)
The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo. (1989) (37)
The offspring of bipolar manic-depressives: clinical features. (1982) (36)
Biochemical aspects of lithium in affective disorders. (1968) (35)
The relationship of atypical lymphocytes, phenothiazines, and schizophrenia. (1966) (35)
Life events and primary affective illness (1978) (33)
Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. (1999) (32)
Linkage studies in affective disorders: the Xg blood group and manic-depressive illness. (1975) (31)
Coexistent manic symptoms and multiple sclerosis. (1981) (31)
Patient rejection of lithium carbonate prophylaxis. (1971) (31)
Classification of bipolar affective disorder subtypes. (1982) (30)
Assortative mating in affective disorders. (1981) (29)
The Effect of Lithium Carbonate on the Electroencephalogram of Patients with Affective Disorders (1969) (29)
Erythrocyte catechol-o-methyltransferase activity in primary affective disorder. (1977) (29)
Attempted suicide in manic-depressive disorder. (1984) (28)
Treatement of excessive weight gain in patients taking lithium. (1976) (27)
The relationship of family history of alcoholism to primary affective disorder. (1979) (27)
Patients' and informants' reports of personality traits during and after major depression. (1994) (27)
L-tryptophan in depression. (1976) (27)
Lithium retention and excretion. The effect of sodium and fluid intake. (1969) (26)
Amino acid concentrations in cerebrospinal fluid: effects of aging, depression, and probenecid. (1980) (26)
Episode frequency prior to lithium treatment in bipolar manic-depressive patients. (1979) (26)
Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders (2016) (26)
Prostaglandins. A review of neurophysiology and psychiatric implications. (1977) (25)
The use of Autocorrelation Analysis in the Longitudinal Study of Mood Patterns in Depressed Patients (1976) (25)
Moodswing, the third revolution in psychiatry (1975) (25)
The measurement of lithium in biologic samples by atomic absorption spectrophotometry. (1968) (24)
Cholinesterase activity and the manic depressive patients. (1975) (24)
Follow-up studies of lithium and thyroid function in manic-depressive illness. (1969) (24)
Absorption and excretion of lithium in manic-depressive disease. (1968) (24)
Lithium elimination half‐life and duration of therapy (1981) (23)
Inter‐episode major and subclinical symptoms in affective disorder (1987) (23)
Calmodulin-activated calcium ATPase in bipolar illness. (1988) (23)
Atomic Absorption Spectrophotometry of Rubidium in Biological Fluids (1970) (23)
Prophylaxis with lithium carbonate: an update. (1982) (22)
The dexamethasone suppression test as a monitor of clinical recovery. (1987) (20)
Rubidium chloride ingestion by volunteer subjects: Initial experience (2004) (20)
Pattern analysis of antidepressant response to fluoxetine. (1986) (20)
Histocompatibility antigens in affective disorders. (1977) (19)
Cogwheel rigidity during chronic lithium therapy. (1979) (19)
Age of onset of affective illness. (1982) (19)
Clinical correlates of the lithium pump. (1978) (18)
Antecedent life events, social supports and response to antidepressants in depressed patients (1996) (18)
Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction? (1990) (18)
Active efflux of lithium from erythrocytes of manic-depressive subjects. (1976) (18)
The effect of lithium chloride administration on brain and heart norepinephrine turnover rates (2005) (17)
Psychiatric illness in fathers of men with bipolar primary affective disorder. (1975) (17)
Marital adjustment in primary affective disorder. (1978) (17)
Affective Disorder on Paternal and Maternal Sides (1973) (17)
Platelet monoamine oxidase activity in affective disorder. (1980) (17)
Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGI change. (1987) (16)
The Place of Lithium in Biological Psychiatry (1980) (16)
Repression of a lithium pump as a consequence of lithium ingestion by manic-depressive subjects (1977) (16)
Double-blind procedure: an assessment in a study of lithium prophylaxis (1975) (16)
Actuarial studies of the course of manic-depressive illness. (1978) (16)
Social adjustment in primary affective disorder. (1978) (15)
Renal impairment, hypercalcemia, and lithium therapy. (1981) (15)
General behavior inventory: measurement of subclinical changes during depression and lithium prophylaxis (1986) (15)
Lithium pharmacokinetics, duration of therapy, and the adenylate cyclase system. (1982) (14)
Lithium carbonate prophylaxis of depression in three subtypes in primary affective disorder. (1976) (14)
Construction and evaluation of a test for measuring mania and depression. (1970) (14)
Effect of lithium therapy on glomerular filtration rate. (1983) (14)
Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. (1965) (13)
Repression and reactivation of lithium efflux from erythrocytes (1979) (13)
Effect of lithium on glycine levels in patients with affective disorders. (1981) (12)
Lithium-induced changes in electrolyte balance and tissue electrolyte concentration (2004) (12)
Lithium prophylaxis in affective disorders. (1975) (12)
Lithium erythrocyte: plasma ratio in primary affective disorder. (1978) (12)
Relationship of dose to antidepressant prophylactic efficacy (1991) (11)
The effect of lithium on red blood cell cholinesterase activity in patients with affective disorders. (1976) (11)
Rubidium: overview and clinical perspectives. (1982) (11)
The Predictive Value of the Dexamethasone Suppression Test (1989) (11)
The prophylactic efficacy of tricyclic antidepressants—A five year followup (1991) (10)
The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level. (1979) (10)
Three alternatives to the double-blind. (1969) (10)
Lithium level and inter‐episode symptoms in affective disorder (1987) (10)
Sequelae of neuroleptic malignant syndrome (1987) (9)
Overview of Therapeutic and Prophylactic Trials with Lithium in Psychiatric Patients (1973) (9)
Effect of mood and lithium carbonate on total body potassium. (1970) (9)
Fluoxetine Response: Endpoint vs Pattern Analysis (1986) (9)
Application of an improved cerebroventricular perfusion technique in the rabbit: Effects of pentobarbital or haloperidol on monoamine metabolites and proteins in the perfusate (1978) (8)
The lithium clinic: a new model for the delivery of psychiatric services. (1975) (8)
Plasma lithium level and interepisode functioning in bipolar disorder. (1985) (8)
Prostaglandin F in patients with primary affective disorder. (1977) (8)
Body composition in affective disorder before, during, and after lithium carbonate therapy. (1982) (8)
Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. (1988) (7)
Transmission of Manic-Depressive Illness (1973) (7)
Bioavailability of lithium carbonate: single versus multiple daily dosing. (1981) (7)
Lithium-associated nephropathy. (1979) (7)
Affective episode frquency and lithium therapy. (1980) (6)
Platelet 3H-imipramine binding and familial transmission of affective disorders. (1987) (6)
The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients. (1986) (6)
Lamotrigine or lithium in the maintenance treatment of bipolar I disorder (2002) (6)
A dominant X-linked factor in manic-depressive illness: studies with color blindness. (1975) (6)
Differences in lithium kinetics between bipolar and unipolar patients. (1982) (5)
The Revolution Defined: It Is Pharmacologic (1977) (5)
Relationship between plasma lithium levels and prophylaxis against depression in bipolar I, bipolar II, and cyclothymic patients. (1982) (5)
Metabolism of naturally occurring Rb in the human: the constancy of urinary Rb-K. (1973) (5)
Sleep in Depression and Mania (1970) (5)
Self-Concepts Associated with Mania and Depression (1970) (4)
Adjunctive open-label topiramate in bipolar disorder (2001) (4)
Prophylactic lithium? (1968) (4)
Affective disorder: studies with amine precursors. (1975) (4)
Repeated measurements in the manic-depressive illness: some methodological problems. (1968) (4)
Proceedings: Rubidium salts--toxic effects in humans and clinical effects as an antidepressant drug. (1974) (4)
Rubidium replacement of total body potassium in humans. (1980) (4)
Lithium Prophylaxis and Experimental Rubidium Therapy in Affective Disorders (1987) (4)
Prophylactic effect of lithium against depression in cyclothymic patients: a life-table analysis. (1981) (4)
Maintenance treatment of unipolar depression. (1981) (3)
Cerebrospinal fluid rubidium metabolism in depression (1974) (3)
The case of dominique straus-kahn and mental disorder (2012) (3)
The clinical effects of lithium treatment (1979) (3)
Lead levels in the hair of bipolar patients and normal controls. (1986) (3)
Depressive attributional style and the dexamethasone suppression test: relationship to the endogenous/melancholic distinction and to each other. (1992) (3)
THE EFFECT OF LITHIUM IN DEPRESSIVE SUBTYPES (1978) (3)
Plasma dopamine Β hydroxylase activity in affective disorders (1976) (3)
Stability of the emotional content of early memories in manic-depressive patients. (1970) (3)
CSF AMP in primary affective disorder: effects of probenecid and tryptophan. (1980) (3)
12 – Lithium: an overview (1977) (3)
Evaluation of manic-depressive states with an affect adjective check list. (1971) (2)
Dexamethasone suppression test and response to antidepressants in depressed outpatients. (1982) (2)
Plasma dopamine beta hydroxylase activity in affective disorders. (1976) (2)
Clinical Use of Lithium in Affective Disorders (1977) (2)
Genetic research in psychiatry : proceedings of the sixty-third annual meeting of the American Psychopathological Association (1975) (2)
Lithium and amino acids. (1982) (2)
Lithium pump repression as an indicator of prophylactic response [proceedings]. (1978) (2)
A clinical trial of methysergide and lithium in mania (2004) (2)
Prophylactic serum lithium levels in recurrent unipolar depression. (1981) (2)
Clinical and chemical effects of lithium discontinuation. (1987) (2)
Clinical Features, DST, and Response to Placebo in Depressed Outpatients (1989) (2)
Dexamethasone suppression test in predicting response to tricyclic antidepressants in depressed outpatients. (1985) (2)
Suppression of amphetamine-induced EEG arousal in the hippocampus of haloperidol-treated rabbits. (1981) (2)
Clinical and Chemical Effects of Lithium Discontinuation (1987) (2)
Lithium and thyroid function. Reply. (1969) (2)
Depression: Its Diagnosis and Treatment; Lithium: The History of Its Use in Psychiatry (1970) (2)
Bipolar II--a distinct diagnostic entity? (1981) (2)
Affective disease health maintenance organization. Patterns of lithium response. (1974) (2)
Factors affecting lithium efflux from human erythrocytes [proceedings]. (1978) (2)
Renal impairment and lithium. (1979) (1)
Drs. Fieve and Platman Reply (1969) (1)
Depression: The Facts (1985) (1)
The use of nonphysicians in a health maintenance program for affective disorders. (1974) (1)
An Investigation of Electrolyte and Fluid Distribution in the Affective Disorders. (1969) (1)
Manic-Depressive Illness (1970) (1)
The importance of dietary control in metabolic studies of manic-depressive patients. (1980) (1)
Erythrocyte glycine in depressed, hypomanic, and euthymic bipolar patients treated with lithium carbonate (2004) (1)
Managing adverse effects of mood stabilizers (2007) (0)
CATECHOLAMINE METABOLIZING ENZYMES AND PRIMARY AFFECTIVE DISORDERS (1979) (0)
The use of lithium in the affective psychoses. 1966. (1994) (0)
The lithium clinic: a new model for the delivery of psychiatric services. (1977) (0)
Subject Index Vol. 20, 1988 (1988) (0)
Schizoaffective Disorder: Criteria and Prevalence-Reply (1981) (0)
The Prophylaxis of Unipolar Depression (1993) (0)
Contents of the American Journal of Psychiatry (1993) (0)
Clinical Controversies and Theoretical Mode of Action of Lithium Carbonate (1970) (0)
Does lithium in drinking water prevent mental disorder (1974) (0)
Lithium studies and manic-depressive illness. (1972) (0)
Repeated measurements in the manic-depressive illness: some methodological problems. (1968) (0)
Atomic AbsorptionSpectrophotometryof Rubidium in BiologicalFluids (2004) (0)
Biochemistry of Mental Disorders (1981) (0)
Longitudinal Studies of Diurnal Variations in Depression: A Sample of 643 Patient Days (1973) (0)
LITHIUM IN PSYCHIATRY (1970) (0)
The lithium clinic for treatment and prevention of manic depression: a cost benefit approach. (1979) (0)
Depressive Illness: Some Research Studies (1973) (0)
Depression in the 1970's; modern theory and research : proceedings of the symposium, New York, N.Y., Oct. 1970 (1971) (0)
Lithium for manic depressive disorders, challenge to electroshock therapy? (1971) (0)
Course and relationship of lithium side effects to plasma lithium levels. (1981) (0)
P-180 USE OF LIPID LOWERING AGENTS AND THE RISK OF COGNITIVE IMPAIRMENT NOT MEETING DEMENTIA CRITERIA IN RELATION TO APOLIPOPROTEIN E STATUS (2005) (0)
Norepinephrine metabolism in mouse heart after lithium and rubidium treatment. (1975) (0)
ers lity traits an (1992) (0)
Lithium in psychiatry: reply to discussants. (1970) (0)
important factor in planning of long-term Li prophylaxis. (1980) (0)
[Lithium salts in psychiatry: indications and mechanisms of action]. (1972) (0)
A pilot data analysis on the Columbia University lithium archives project (2005) (0)
Lithium discontinuation, serum cortisol, and 5-HTP. (1987) (0)
Contents of The American Journal of Psychiatry (1987) (0)
Lithium poisoning. (1987) (0)
[The repression of the lithium pump as an indicator of the response to prophylactic treatment]. (1980) (0)
[The research of new antidepressants: present orientations (author's transl)]. (1979) (0)
[Affective equivalents in depressive and manic-depressive patients]. (1973) (0)
How Much Food from the Sea? (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ronald R. Fieve?

Ronald R. Fieve is affiliated with the following schools:

Columbia University